Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04981925 · ClinicalTrials.gov registry record · NA

Predictors of Pain Relief From Mindfulness-based Stress Reduction (MBSR) in Multiple Forms of Chronic Pain Patients

A NA study of Chronic Pain Syndrome, sponsored by University of Michigan.

Completed
Registry status
NA
Development phase
381
Enrollment target
1
Study location

NCT04981925 is a NA study of Chronic Pain Syndrome that has completed, run by University of Michigan. The registered enrollment target is 381 participants, above the 46-participant average among 7 other Chronic Pain Syndrome trials with a reported enrollment target (728% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04981925, a NA study of Chronic Pain Syndrome, has completed, sponsored by University of Michigan.

COMPLETED
Registry status
NA
Development phase
381 participants
Enrollment target
1
Study location

Study Summary

The overall objective of this study is to better understand how Mindfulness-based Stress Reduction (MBSR) is the most helpful in terms of management of chronic pain symptoms. The studies hypothesis is that an Interventional Response Phenotyping study (light phenotyping) can identify individuals with different underlying mechanisms for their pain who thus respond differentially to evidence-based interventions for chronic pain disorders.

Conditions Studied

Interventions

  • BEHAVIORAL MBSR treatment

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 381 participants
Start Date 2021-08-01
Est. Completion 2025-02-27
Phase NA

Sponsor

University of Michigan

1,327 total trials

What the Registry Record Tells You About NCT04981925

The ClinicalTrials.gov registry entry for NCT04981925 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 381 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 46-participant average among 7 other Chronic Pain Syndrome trials with a reported enrollment target (728% higher). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Pain Syndrome appearing as the primary indexed condition, and to 1 intervention - of which MBSR treatment is the first listed.

NCT04981925 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT04981925 about?

NCT04981925 is a clinical study titled "Predictors of Pain Relief From Mindfulness-based Stress Reduction (MBSR) in Multiple Forms of Chronic Pain Patients". The overall objective of this study is to better understand how Mindfulness-based Stress Reduction (MBSR) is the most helpful in terms of management of chronic pain symptoms. The studies hypothesis is that an Interventional Response Phenotyping study (light phenotyping) can identify individuals wit...

What is the current status of trial NCT04981925?

This trial is currently completed. It is a NA study. The enrollment target is 381 participants. The study started on 2021-08-01. Estimated completion is 2025-02-27.

What conditions does trial NCT04981925 study?

This clinical trial studies the following conditions: Chronic Pain Syndrome.

What interventions are being tested in trial NCT04981925?

The interventions under investigation include: MBSR treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT04981925?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04981925 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.